Compare Invesco Solar ETF (TAN) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Solar ETF vs Zimmer Biomet Holdings Inc — how do they compare? Invesco Solar ETF trades at $47.5, while Zimmer Biomet Holdings Inc trades at $94.63 (market cap $18.05B). The key difference: Zimmer Biomet Holdings Inc pays a 1.01% dividend while Invesco Solar ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals.
| TAN | ZBH | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $73.95 | $104.26 |
52-Week Low | $41.78 | $79.58 |
Market Cap | — | $18.05B |
Enterprise Value | — | $25.11B |
Dividend Yield | — | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TAN trades at $49.13, up 2.27% today, but technical signals are bearish with moving averages indicating selling pressure. The ETF faces mixed sentiment, with recent news highlighting both policy tailwinds from U.S. polysilicon tariffs and headwinds from market saturation concerns. Financial ratios are unavailable, but the fund's high expense ratio of 0.7% and volatility remain notable.
Outlook is cautious; while geopolitical shifts and AI-driven power demand support long-term solar growth, near-term risks include price deflation, regulatory delays, and underperformance versus broader markets. Investors should weigh sector potential against persistent volatility and cost inefficiencies.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
